At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 66 enrolled
Drug / intervention
Oxycodone Hydrochloride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 5-day, Multicentre, Randomized, Open-label, Parallel Group, Active Control Pilot Study to Evaluate the Efficacy and Safety of OxyNorm® (Oxycodone Hydrochloride Injection) in Comparison With Morphine Sulfate Through the IV Continuous Infusion Regimen in Patients With Cancer Pain
In Brief
A Phase 4 clinical trial evaluating Oxycodone Hydrochloride and Morphine Sulphate for Cancer Pain. Completed, enrolled 66 participants across 1 site.
Detailed Summary
The purpose of this study is to compare of difference in NRS scores from baseline to the completion of treatment (5 days) in patients with administration of morphine sulfate versus oxycodone hydrochloride.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer Pain
CountriesSouth Korea
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedJan 2016
Primary CompletionJul 2016
TodayJul 2026
First PostedJan 21, 2016
Enrollment StartNov 1, 2015
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.4 years ago
Interventions
Oxycodone Hydrochloridedrug
Oxycodone injection
Morphine Sulphatedrug
Morphine sulphate injection